# Fortress Biotech, Inc.: Form 8-K, filed Jan 31, 2019

- Company: [Fortress Biotech, Inc.](/companies/fbio.md) (CIK 1429260)
- Form: 8-K
- Filed: 2019-01-31
- Accepted by EDGAR: Jan 31, 2019, 07:52 ET
- Period: 2019-01-30
- Accession: 0001144204-19-003899
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1429260/000114420419003899/tv512065_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1429260/000114420419003899/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1429260/000114420419003899/tv512065_8k.htm

Filed Jan 31, 2019.
Source: SEC EDGAR, the filing index for accession 0001144204-19-003899. Last ingested by Listed: Nov 14, 2026, 11:27 ET. No prices; not investment advice.
